Cargando…
Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine
BACKGROUND: For over two decades, a racemic mixture of oxamniquine (OXA) was administered to patients infected by Schistosoma mansoni, but whether one or both enantiomers exert antischistosomal activity was unknown. Recently, a ~30 kDa S. m ansoni sulfotransferase (SmSULT) was identified as the targ...
Autores principales: | Taylor, Alexander B., Pica-Mattoccia, Livia, Polcaro, Chiara M., Donati, Enrica, Cao, Xiaohang, Basso, Annalisa, Guidi, Alessandra, Rugel, Anastasia R., Holloway, Stephen P., Anderson, Timothy J. C., Hart, P. John, Cioli, Donato, LoVerde, Philip T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618941/ https://www.ncbi.nlm.nih.gov/pubmed/26485649 http://dx.doi.org/10.1371/journal.pntd.0004132 |
Ejemplares similares
-
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
por: Rugel, Anastasia R., et al.
Publicado: (2020) -
An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans
por: Guzman, Meghan A., et al.
Publicado: (2020) -
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023) -
Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments
por: Toth, Katalin, et al.
Publicado: (2023) -
Oxamniquine resistance alleles are widespread in Old World Schistosoma mansoni and predate drug deployment
por: Chevalier, Frédéric D., et al.
Publicado: (2019)